Science

Emre Yekedüz: A new era has started in the treatment of kidney cancer

Emre Yekedüz/X

Feb 8, 2025, 06:51

Emre Yekedüz: A new era has started in the treatment of kidney cancer

Emre Yekedüz, Associate Professor of Medical Oncology at Ankara University, shared an article by David A. Braun, et al. on X:

“A new era has just started in the treatment of kidney cancer!

This masterpiece study put novel insights on RCC treatment!

A Phase I trial of a personalized cancer vaccine in high-risk RCC shows no recurrences in 9 patients, strong T-cell responses against driver mutations (VHL, PBRM1, BAP1, etc.), and durable immune activation.”‘

A neoantigen vaccine generates antitumour immunity in renal cell carcinoma.

Authors: David A. Braun, et al.

Emre Yekedüz: A new era has started in the treatment of kidney cancer

Ankara University cancer David A. Braun Emre Yekedüz fight against cancer Global fight against cancer kidney cancer MedOnc neoantigen vaccine OncoDaily Oncology RCC renal cell carcinoma

Senator John Fetterman Responds to Oncodaily on Pediatric Oncology Funding

Does Processed Meat Cause Cancer? Myths and Facts

Global Health Dialogues with Princess Dina Mired | Episode 1: Dr. Firas Al-Hawari

NEW PAPER ALERT: ESOPEC trial on Perioperative Chemotherapy or Preoperative Chemoradiotherapy in Esophageal Cancer

Oncologist Near Me - Matti Aapro: Pioneering Excellence in Cancer Care and Geriatric Oncology